Aligos Therapeutics's total assets for Q3 2024 were $88.43M, a decrease of -18.73% from the previous quarter. ALGS total liabilities were $38.33M for the fiscal quarter, a -7.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.